Cardiology clinical trial participation in community-based healthcare systems: obstacles and opportunities.
Cardiology clinical trial participation in community-based healthcare systems: obstacles and opportunities.
复制标题
心脏病学临床试验参与社区医疗保健系统：障碍和机遇。
DOI：
10.1016/j.cct.2008.02.003
复制
发表时间：
2008
影响因子：
2.2
通讯作者：
Go,AlanS
中科院分区：
文献类型：
--
作者：
Somkin,CarolP;Altschuler,Andrea;Ackerson,Lynn;Tolsma,Dennis;Rolnick,SharonJ;Yood,Robert;Weaver,WDouglas;VonWorley,Ann;Hornbrook,Mark;Magid,DavidJ;Go,AlanS
BACKGROUNDThe objective of our study was to examine cardiologists' and organizational leaders' interest in clinical trial participation and perceived barriers and facilitators to participation within ten diverse non-profit healthcare delivery systems. Trials play a pivotal role in advancing knowledge about the safety and efficacy of cardiovascular interventions and tests. Although cardiovascular trials successfully enroll patients, recruitment challenges persist. Community-based health systems could be an important source of participants and investigators, but little is known about community cardiologists' experiences with trials.METHODSWe interviewed 25 cardiology and administrative leaders and mailed questionnaires to all 280 cardiologists at 10 U.S. healthcare organizations.RESULTSThe survey received a 73% response rate. While 60% of respondents had not participated in any trials in the past year, nearly 75% wanted greater participation. Cardiologists reported positive attitudes toward trial participation; more than half agreed that trials were their first choice of therapy for patients, if available. Almost all leaders described their organizations as valuing research but not necessarily trials. Major barriers to participation were lack of physician time and insufficient skilled research nurses.CONCLUSIONSCardiologists have considerable interest in trial participation. Major obstacles to increased participation are lack of time and effective infrastructure to support trials. These results suggest that community-based health systems are a rich source for cardiovascular research but additional funding and infrastructure are needed to leverage this resource.
